USD 0.89
(7.23%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 118.72 Million USD | -7.87% |
2022 | 128.59 Million USD | 0.32% |
2021 | 128.17 Million USD | 6.33% |
2020 | 120.55 Million USD | -14.75% |
2019 | 141.41 Million USD | -47.82% |
2018 | 271.01 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 28.45 Million USD | 13.7% |
2024 Q3 | 23.77 Million USD | 2.63% |
2024 Q2 | 23.16 Million USD | -18.59% |
2023 Q4 | 25.02 Million USD | -11.99% |
2023 FY | 118.47 Million USD | -7.87% |
2023 Q3 | 28.43 Million USD | -26.97% |
2023 Q2 | 38.93 Million USD | 12.13% |
2023 Q1 | 34.72 Million USD | 15.39% |
2022 Q1 | 35.12 Million USD | 9.79% |
2022 Q2 | 35.31 Million USD | 0.53% |
2022 FY | 128.59 Million USD | 0.32% |
2022 Q4 | 30.09 Million USD | 7.23% |
2022 Q3 | 28.06 Million USD | -20.54% |
2021 FY | 128.17 Million USD | 6.33% |
2021 Q4 | 31.99 Million USD | -6.74% |
2021 Q3 | 34.3 Million USD | 14.45% |
2021 Q2 | 29.97 Million USD | -6.02% |
2021 Q1 | 31.89 Million USD | -4.4% |
2020 Q4 | 33.36 Million USD | 15.19% |
2020 Q2 | 28.73 Million USD | -58.38% |
2020 FY | 120.55 Million USD | -14.75% |
2020 Q1 | 69.03 Million USD | 0.0% |
2020 Q3 | 28.96 Million USD | 0.81% |
2019 FY | 141.41 Million USD | -47.82% |
2018 FY | 271.01 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Oncology Network, Inc. | 83.97 Million USD | -41.385% |
Assure Holdings Corp. | 15.43 Million USD | -669.014% |
Novo Integrated Sciences, Inc. | 13.5 Million USD | -779.084% |
Panamera Holdings Corporation | 7.12 Million USD | -1566.112% |